Loading…

Browse All Grants

606,025 grants found

Filters
Reset

Showing 33,80133,820 of 606,025 grants

Active NON-SBIR/STTR RPGS
Project 2: mRNA vaccine development against Bunyaviruses, Paramyxoviruses and Picornaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California-Irvine United States 2024 – 2027

Project Summary/Abstract – Project 2: mRNA Vaccine Development against Bunyaviruses, Paramyxoviruses and Picornaviruses As the emergence of new pathogenic outbreaks in the future i...

Active NON-SBIR/STTR RPGS
Project 3: Peribunyaviridae Pathogenesis and Vaccine Testing
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California-Irvine United States 2024 – 2027

Project Summary/Abstract – Project 3: Peribunyaviridae Pathogenesis and Vaccine Testing The orthobunyaviruses (OBVs) of Peribunyviridae cause disease in humans manifesting with fev...

Active NON-SBIR/STTR RPGS
Project 5: Multi-scale development and evaluation of broadly-effective vaccines against picornaviruses with pandemic potential
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California-Irvine United States 2024 – 2027

Project Summary/Abstract – Project 5: Multi-scale development and evaluation of broadly-effective vaccines against picornaviruses with pandemic potential Picornaviruses are the mos...

Active NON-SBIR/STTR RPGS
Bunyavirus and Picornavirus Pandemic Pathogen Preparedness (BP4) Center
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

Project Summary Pathogenic picornaviruses and bunyaviruses have an enormous impact on public health worldwide, and our understanding of mechanistic correlates of immunity for membe...

$380.56M
USD
Active NON-SBIR/STTR RPGS
Admin-Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY - CORE A The central offices and administrative staff of the Vanderbilt Vaccine Center (VVC) will house the BP4 Administrative Core, which will play a critical role...

Active NON-SBIR/STTR RPGS
Data-Management-Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY- CORE B The Data Management and Sharing (DMS Core) will be integral to the Bunyavirus and Picornavirus Pandemic Pathogen Preparedness (BP4) Center. The DMS Core wil...

Active NON-SBIR/STTR RPGS
Structural Biology Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY - CORE C Bunyaviruses and Picornaviruses are RNA viruses that cause outbreaks of human disease. Given their diversity and mechanisms of transmission, they represent...

Active NON-SBIR/STTR RPGS
Vaccines and Therapeutics Technology Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY - CORE D The Vaccine and Therapeutics Technologies (VTT) Core will focus on developing a rapid pipeline for next- generation vaccine and therapeutic antibody candid...

Active NON-SBIR/STTR RPGS
Virologic and Immunologic Sample Acquisition Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY – CORE E Virologic and Immunologic Sample Acquisition Core (VISAC) Preparedness for the next pandemic relies upon improved understanding of both emerging viruses an...

Active NON-SBIR/STTR RPGS
Design and testing picornavirus vaccine candidates
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY – RP1 Design and testing of picornavirus vaccine candidates The need for effective vaccines against enteroviruses and rhinoviruses cannot be overstated. Given the e...

Active NON-SBIR/STTR RPGS
Protective human antibodies for picornaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY - RP2 Picornaviruses are an ever-present threat to human health, causing myriad diseases ranging from mild (common colds, hand, foot, and mouth disease) to more sev...

Active NON-SBIR/STTR RPGS
Nucleic acid vaccines targeting hantaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY – RP3 RNA vaccines are one of the most promising vaccine platforms available to rapidly deploy in response to emerging viral infections with pandemic potential. How...

Active NON-SBIR/STTR RPGS
Human monoclonal antibodies for hantaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY – RP4 The hantaviruses represent collections of diverse virus species, and these groups of viruses are ideal for prototype pathogen immunity approaches. The goal of...

Active NON-SBIR/STTR RPGS
Vaccines and antibodies for arenaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Vanderbilt University Medical Center United States 2024 – 2027

PROJECT SUMMARY - RP5 Arenaviruses, a family of viruses with pandemic potential, can cause hemorrhagic fever, meningitis, and other clinical syndromes. These viruses include highly...

Completed OTHER RESEARCH-RELATED
Metasurface Optical Guidewire for percutaneous coronary intervention (PCI)
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of California-Irvine United States 2024 – 2026

PROJECT SUMMARY / ABSTRACT Coronary artery disease, aggravated by arterial calcification, poses a significant challenge to successful percutaneous coronary intervention (PCI). Coro...

$1.34M
USD
Active OTHER RESEARCH-RELATED
Optimizing Equitable Peanut Allergy Prevention among Infants at High Risk of Peanut Allergy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Yale University United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Peanut allergy affects one in fifty children in the US with disparities in prevalence and morbidity. There is no cure, and while progress is being made in...

$1.95M
USD
Active NON-SBIR/STTR RPGS
Understanding Mechanisms of Antibiotic Inhibition of Ribosomal Subunit Joining
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES University of Arkansas At Fayetteville United States 2024 – 2027

Project Summary / Abstract Antimicrobial resistance is rapidly on the rise due to the excessive use and over-prescription of antibiotics in agriculture and medicine. Consequently,...

$4.03M
USD
Active NON-SBIR/STTR RPGS
Applied Implementation Research for Clean Cooking in Cambodia (AIR-C3): equity, exposure, costs, and benefits of induction stove interventions
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCE... Emory University United States 2024 – 2029

The goal of this study—Applied Implementation Research for Clean Cooking in Cambodia (AIR-C3)—is to design and demonstrate the effectiveness of a scalable strategy for achieving eq...

$11.7M
USD
Active NON-SBIR/STTR RPGS
Nanohybrid Composites Minimize Antibiotic Resistant Infections
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... West Virginia University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: Open fractures are frequently (more than 150,000 cases in the U.S. every year) seen and have high (~10%) infection rates. Open fracture-associated infecti...

$3.8M
USD
Active NON-SBIR/STTR RPGS
Genetic screens in zebrafish to identify gene-ethanol interactions
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM University of Texas At Austin United States 2024 – 2029

Project Summary/Abstract Ethanol is the most common teratogen and the leading cause of mental retardation. Fetal alcohol exposure can cause numerous birth defects, most commonly ef...

$3.52M
USD